High Δ CRP/Alb group (n = 13) | Low Δ CRP/Alb group (n = 36) | p value | |
---|---|---|---|
Age (years) | 74 | 68 | 0.1663 |
Sex: female | 6 (46.2) | 16 (44.4) | 0.916 |
Tumor size (mm) | 30 | 20 | 0.076 |
<Pre-NACRT> | |||
CEA (ng/mL) | 5.5 | 3.9 | 0.1235 |
CA19-9 (U/mL) | 537 | 214 | 0.1889 |
FDG-PET (SUVmax) | 7.8 | 7.0 | 0.5926 |
Resectability: BR | 2 (15.4) | 6 (16.7) | 0.9155 |
BMI | 23.5 | 22.1 | 0.1129 |
CRP (mg/dL) | 0.41 | 0.16 | 0.0698 |
Alb (g/dL) | 3.8 | 3.9 | 0.7941 |
NLR | 2.51 | 2.00 | 0.0852 |
GPS 2 or 1 | 4 (30.8) | 10 (27.8) | 0.8395 |
mGPS 2 or 1 | 2 (15.4) | 3 (8.3) | 0.4761 |
<Post-NACRT> | |||
CEA (ng/mL) | 6.5 | 3.5 | 0.1333 |
CA19-9 (U/mL) | 455 | 107 | 0.0728 |
ΔWeight loss (kg) | 1.55 | 0.48 | 0.0314 |
CRP (mg/dL) | 1.32 | 0.08 | < 0.0001 |
Alb (g/dL) | 3.2 | 3.9 | 0.0015 |
NLR | 3.20 | 3.34 | 0.9639 |
GPS 2 or 1 | 11 (84.6) | 10 (27.8) | 0.0004 |
mGPS 2 or 1 | 10 (76.9) | 0 (0) | < 0.0001 |
<Perioperative and postoperative factor> | |||
Intraoperative bleeding (mL) | 1764 | 1005 | 0.0666 |
Complication after surgerya | 2 (15.4) | 10 (27.8) | 0.3780 |
Postoperative hospital stays (days) | 29 | 25 | 0.5183 |
T3 | 2 (15.4) | 5 (13.9) | 0.8960 |
N2 or N1 | 7 (53.8) | 18 (50.0) | 0.8139 |
PVI | 5 (38.5) | 10 (27.8) | 0.4783 |
Surgical margin: R1 | 4 (30.8) | 10 (27.8) | 0.8395 |
Evans I or IIa | 11 (84.6) | 22 (61.1) | 0.1252 |
Uncompleted adjuvant chemotherapy | 7 (53.9) | 15 (41.7) | 0.4539 |